Faculty Opinions recommendation of Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.

2013 ◽  
Author(s):  
April W Armstrong ◽  
Tara Rachakonda
Keyword(s):  
Narrow Band ◽  
Broad Band ◽  
Ultraviolet B ◽  
Ultraviolet A

Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial

The Lancet ◽  
2001 ◽  
Vol 357 (9273) ◽  
pp. 2012-2016 ◽  
Author(s):  
Nick J Reynolds ◽  
Vera Franklin ◽  
Janine C Gray ◽  
Brian L Diffey ◽  
Peter M Farr
Keyword(s):  
Randomised Controlled Trial ◽  
Atopic Eczema ◽  
Narrow Band ◽  
Controlled Trial ◽  
Broad Band ◽  
Ultraviolet B ◽  
Ultraviolet A ◽  
Randomised Controlled

Safe and effective use of phototherapy and photochemotherapy in the treatment of psoriasis

2020 ◽  
Vol 29 (10) ◽  
pp. 547-552
Author(s):  
Joanna Campbell
Keyword(s):  
Side Effects ◽  
Inflammatory Disease ◽  
Narrow Band ◽  
Ultraviolet B ◽  
Second Line ◽  
Skin Involvement ◽  
Ultraviolet A ◽  
History Of ◽  
Effective Use

Psoriasis is a chronic, multisystem inflammatory disease, predominantly affecting the skin and joints, which is present in 2−3% of the world's population. Narrow band ultraviolet B (NB-UVB) and Psoralen + ultraviolet A (PUVA) are recognised, effective and, in the case of UVB, economical second-line treatments for psoriasis where topical therapies fail to control the disease or are an impracticable option due to the extent of skin involvement. This article examines the history of phototherapy and photochemotherapy and looks at current phototherapy treatments used for psoriasis. It discusses side effects of treatment and regimens that can be followed to increase effectiveness of treatment and minimise risks. The role of the nurse phototherapist is also discussed.

Sign in / Sign up

Export Citation Format

Share Document